IL-6 has no acute effect on the regulation of urea synthesis in vivo in rats

References

• Klein S, Meyers S, O'Sullivan P, Barton D, Leleiko N, Janowitz HD. The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance. J Clin Gastroenterol 1988;10:34–40.
   PubMed Web of Science ®Google Scholar
• Walsmith J, Abad L, Kehayias J, Roubenoff R. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 2004;31:23–9.
   PubMed Web of Science ®Google Scholar
• Heindorff H, Vilstrup H, Bucher D, Billesbolle P, Thygesen V. Increased hepatic amino nitrogen conversion after elective cholecystectomy in man. Clin Sci (Lond) 1988;74:539–45.
   PubMed Web of Science ®Google Scholar
• Almdal TP, Petersen KF, Hansen BA, Vilstrup H. Increased capacity of urea synthesis in streptozotocin diabetes in rats. Diabetologia 1986;29:812–6.
   PubMed Web of Science ®Google Scholar
• Lundsgaard C, Hamberg O, Thomsen OO, Nielsen OH, Vilstrup H. Increased hepatic urea synthesis in patients with active inflammatory bowel disease. J Hepatol 1996;24: 587–93.
   PubMed Web of Science ®Google Scholar
• Nielsen SS, Grofte T, Tygstrup N, Vilstrup H. Effect of lipopolysaccharide on in vivo and genetic regulation of rat urea synthesis. Liver Int 2005;25:177–83.
   PubMed Web of Science ®Google Scholar
• Thomsen KL, Nielsen SS, Aagaard NK, Sandahl TD, Gronbaek H, Frystyk J, Flyvbjerg A, Vilstrup H. Tumor necrosis factor-alpha acutely up-regulates urea synthesis in vivo in rats – a hepatic component of inflammatory catabolism? Scand J Clin Lab Invest 2010;70:151–7.
   PubMed Web of Science ®Google Scholar
• Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997;40:443–8.
   PubMed Web of Science ®Google Scholar
• Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257–66.
   PubMed Web of Science ®Google Scholar
• Fantuzzi F, Del GM, Gisondi P, Girolomoni G. Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis. Expert Opin Ther Targets 2008;12:1085–96.
   PubMed Web of Science ®Google Scholar
• Bradley JR. TNF-mediated inflammatory disease. J Pathol 2008;214:149–60.
   PubMed Web of Science ®Google Scholar
• Shalaby MR, Waage A, Aarden L, Espevik T. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989;53:488–98.
   PubMedGoogle Scholar
• Goodman MN. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 1994;205: 182–5.
   PubMed Web of Science ®Google Scholar
• Tabuchi S, Gotoh T, Miyanaka K, Tomita K, Mori M. Regulation of genes for inducible nitric oxide synthase and urea cycle enzymes in rat liver in endotoxin shock. Biochem Biophys Res Commun 2000;268:221–4.
   PubMed Web of Science ®Google Scholar
• Nielsen SS, Grofte T, Tygstrup N, Vilstrup H. Synthesis of acute phase proteins in rats with cirrhosis exposed to lipopolysaccharide. Comp Hepatol 2006;5:3.
   PubMedGoogle Scholar
• Thomsen KL, Nielsen SS, Gronbiek H, Flyvbjerg A, Vilstrup H. Effects of lipopolysaccharide endotoxin on the insulin-like growth factor I system in rats with cirrhosis. In Vivo 2008;22:655–61.
   PubMed Web of Science ®Google Scholar
• Fawcett JK, Scott JE. A rapid and precise method for determination of urea. J Clin Pathol 1960;13:156–9.
   PubMed Web of Science ®Google Scholar
• Goodwin JF. Spectrofotometric quantitation of plasma and urinary amino nitrogen with flourid. St Meth Clin Chem 1970;89–98.
   Google Scholar
• Hansen BA, Vilstrup H. A method for determination of the capacity of urea synthesis in the rat. Scand J Clin Lab Invest 1985;45:315–20.
   PubMed Web of Science ®Google Scholar
• Orskov C, Jeppesen J, Madsbad S, Holst JJ. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 1991;87:415–23.
   PubMedGoogle Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412–9.
   PubMed Web of Science ®Google Scholar
• Gronbaek H, Frystyk J, Orskov H, Flyvbjerg A. Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats. J Endocrinol 1995;145:105–12.
   PubMed Web of Science ®Google Scholar
• Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986;154:138–43.
   PubMed Web of Science ®Google Scholar
• Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988;18:717–21.
   PubMed Web of Science ®Google Scholar
• Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL, Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 1998;83:1573–9.
   PubMed Web of Science ®Google Scholar
• Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett 2002;9:211–23.
   PubMed Web of Science ®Google Scholar
• Gaffen SL, Liu KD. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004;28: 109–23.
   PubMed Web of Science ®Google Scholar
• Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008;226:19–28.
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol 1998;16:365–96.
   PubMedGoogle Scholar
• van der Meer MJ, Sweep CG, Rijnkels CE, Pesman GJ, Tilders FJ, Kloppenborg PW, Hermus AR. Acute stimulation of the hypothalamic-pituitary-adrenal axis by IL-1 beta, TNF alpha and IL-6: a dose response study. J Endocrinol Invest 1996;19:175–82.
   PubMed Web of Science ®Google Scholar
• Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127–37.
   PubMed Web of Science ®Google Scholar
• Stith RD, Luo J. Endocrine and carbohydrate responses to interleukin-6 in vivo. Circ Shock 1994;44:210–5.
   PubMedGoogle Scholar
• Sigsgaard I, Almdal T, Hansen BA, Vilstrup H. Dexamethasone increases the capacity of urea synthesis time dependently and reduces the body weight of rats. Liver 1988;8:193–7.
   PubMedGoogle Scholar
• Hansen BA, Krog B, Vilstrup H. Insulin and glucose decreases the capacity of urea-N synthesis in the rat. Scand J Clin Lab Invest 1986;46:599–603.
   PubMed Web of Science ®Google Scholar
• Fan J, Char D, Bagby GJ, Gelato MC, Lang CH. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol 1995;269: R1204–12.
   PubMed Web of Science ®Google Scholar
• Priego T, Granado M, Ibanez dC, I, Martin AI, Villanua MA, Lopez-Calderon A. Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats. J Endocrinol 2003;179:107–17.
   PubMed Web of Science ®Google Scholar